MetaADEDB 2.0 @ LMMD
pyrazolanthrone
(ACPOUJIDANTYHO-UHFFFAOYSA-N)
Structure
SMILES
O=c1c2ccccc2c2c3c1cccc3[nH]n2
Type(s)
Experimental
Molecular Formula:
C14H8N2O
Molecular Weight:
220.226
Log P:
2.6673
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
45.75
CAS Number(s):
129-56-6
Synonym(s)
1.
pyrazolanthrone
2.
1,9-pyrazoloanthrone
3.
2h-dibenzo(cd,g)indazol-6-one
4.
NSC-75890
5.
NSC75890
6.
SP600125
7.
anthra(1,9-cd)pyrazol-6(2H)-one
External Link(s)
MeSHC432165
PubChem Compound8515
BindingDB16018
50024294
50433916
ChEBI90695
CHEMBLCHEMBL7064
CHEMBL1725279
DrugBankDB01782
IUPHAR/BPS Guide to PHARMACOLOGY5273
Therapeutic Target DatabaseD00JXM
D02PVB
ZINC96298875
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abnormalities, Drug-Induced21751222CTD
2Acute Lung Injury28474156CTD
3Chemical and Drug Induced Liver Injury20423716
26218279		CTD
4Cognition Disorders20600246
29289695		CTD
5Colitis26431797CTD
6Edema16644903CTD
7Embryo Loss21751222CTD
8Eye Abnormalities21751222CTD
9Fetal Growth Retardation21751222CTD
10Heart Diseases21873422CTD
11Hypertrophy20060012CTD
12Inflammation21176401CTD
13Jaw Abnormalities21751222CTD
14Mammary Neoplasms, Experimental25330770CTD
15Necrosis25939952CTD
16Neoplasm Invasiveness

View details

22261521
23437203
26514923
27519288
 		CTD
17Neoplasms, Experimental21726611CTD
18Nerve Degeneration17136323CTD
19Pericardial effusion21751222CTD
20Poisoning22155090CTD
21Pulmonary Edema28474156CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.